Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
Article in Frontiers in Oncology (September 2022)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
“An Unexpected Turn of Events After Discontinuing Tyrosine Kinase Inhibitor Use”
Article in Clinical Thyroidology (April 2022)
RUMA and RUPCR in children with Henoch–Schonlein purpura
Article in Journal of Clinical Laboratory Analysis (March 2022)